Skip to content
Screener

Sana Biotechnology SANA Bothell Washington — Accrued Liabilities And Other Liabilities

Similar metrics at other companies

HCI Group logo
HCIConsolidated Variable Interest Entities — Accrued Liabilities And Other Liabilities
$3.81M
Incyte logo
INCYAxatilimab - Commercialization Activities — Accrued and other liabilities
$26.5M
Incyte logo
INCYAxatilimab - Development Activities — Accrued and other liabilities
$1.4M
KB Home logo
KBHHomebuilding — Accrued Liabilities
$704.4M-8.7%
NVR logo
NVRHome Building Segment — Accrued expenses and other liabilities
$311.7M-6.5%
Chemours logo
CCWashington Works West Virginia — Accrual For Environmental Loss Contingencies
$174M+596%

Other financials

Income statement

See full
Operating income-$48.6M+4.0%
Net income-$47.2M+4.4%
EPS (diluted)-$0.17+19.0%

Balance sheet

See full
Cash & equivalents$83.8M-12.8%
Total debt$75.3M-17.5%
Total equity$119.2M-43.0%
Total assets$373.6M-16.1%

Cash flow

See full
Operating cash flow-$37.4M+23.2%
CapEx$288.0K+112%
Free cash flow-$37.7M+22.8%

Valuation

See full
Market cap$1B+35.5%
Enterprise value$996.16M+31.8%

Returns & leverage

See full
Return on equity-147.4%-2,468pp
Debt / equity0.6×+0.2×
Current ratio1.3×-2.1×

Where this comes from

Reported directly by Sana Biotechnology in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesAndOtherLiabilities.

The source filing: Sana Biotechnology’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 4:10 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-216769

In June 2022, the Company entered into a lease agreement for 79,565 square feet of office, laboratory, and manufacturing space located in Bothell, Washington. The initial term of the lease expires in February 2039, with the option to extend the lease for up to three additional five-year terms. The lease agreement also provides for up to $19.9 million for reimbursement of tenant improvements, as well as an additional $8.0 million loan for tenant improvements, available at the Company’s election (the Tenant Improvement Loan). The Company elected to receive the Tenant Improvement Loan in the second quarter of 2024 and is obligated to repay to the landlord monthly over the initial term of the lease with interest at a rate of 6.5% per year. As of March 31, 2026, $0.4 million was included in accrued expenses and other current liabilities and $6.9 million was included in other non-current liabilities. The Company is obligated to pay base rent of approximately $68.8 million over the initial term of the lease. In accordance with the lease agreement, the Company has obtained a letter of credit in the amount of $1.6 million.

Item 1. Financial Statements

FAQ

What is Sana Biotechnology's bothell washington — accrued liabilities and other liabilities?
Sana Biotechnology (SANA) reported bothell washington — accrued liabilities and other liabilities of $400K in Q1 2026.
How has Sana Biotechnology's bothell washington — accrued liabilities and other liabilities changed year-over-year?
Sana Biotechnology's bothell washington — accrued liabilities and other liabilities decreased by 0.0% year-over-year, from $400K to $400K.
What does bothell washington — accrued liabilities and other liabilities mean?
Captures the total short-term obligations related to the Bothell facility operations that have been incurred but not yet paid. This includes items such as utilities, maintenance, or other operational expenses specific to this geographic segment. It provides a snapshot of near-term cash outflows required to maintain current facility operations.

Ask your AI about Sana Biotechnology's bothell washington — accrued liabilities and other liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude